Showing results (11-20 of 544) with videos related to
Sort By:
Pageof 55
Cardiovascular Diabetology|December 11, 2012
Achievement of recommended glucose and blood pressure targets in patients with type 2 diabetes and hypertension in clinical practice - study rationale and protocol of DIALOGUEAnselm K Gitt, Roland E Schmieder, Eva Duetting, et al.BMC Endocrine Disorders|May 3, 2015
Achievement of individualized treatment targets in patients with comorbid type-2 diabetes and hypertension: 6 months results of the DIALOGUE registryRoland E Schmieder, Anselm K Gitt, Cornelia Koch, et al.Current Opinion in Investigational Drugs (London, England : 2000)|August 26, 2009
Novel antiplatelet therapies following percutaneous coronary interventionsIngo Ahrens, Christoph BodeHerz|December 7, 2005
[Future developments in the therapy of acute ST segment elevation myocardial infarction]Martin Moser, Christoph BodeJournal of Thrombosis and Thrombolysis|November 30, 2016
Vitamin K antagonists: relative strengths and weaknesses vs. direct oral anticoagulants for stroke prevention in patients with atrial fibrillationAndreas Zirlik, Christoph BodeJournal of Blood Medicine|March 5, 2014
Clinical utility of rivaroxaban in stroke prevention associated with nonvalvular atrial fibrillation - patient considerationsIngo Ahrens, Christoph BodeHerz|May 20, 2005
[Direct inhibition of thrombin. A new strategy for the treatment of atrial fibrillation and acute coronary syndrome?]Ingo Ahrens, Christoph BodeJournal of Thrombosis and Thrombolysis|May 15, 2010
Antiplatelet therapy for atherothrombotic disease: how can we improve the outcomes?Martin Moser, Christoph BodeCurrent Drug Discovery Technologies|August 16, 2011
New parenteral anticoagulants: focus on factor Xa and thrombin inhibitorsIngo Ahrens, Christoph BodeCurrent Opinion in Cardiology|April 28, 2009
New antithrombotic agents in acute coronary syndromesMartin Moser, Christoph BodePageof 55